Control IOL

DEVICE2 trials

Sponsors

RxSight, Inc.

Conditions

AphakiaCataract

Unknown Phase

Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery

CompletedNCT03660865

RxSight, Inc.Aphakia, Cataract

Start: 2018-08-28End: 2020-04-01Updated: 2021-12-23

RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study

CompletedNCT05202808

RxSight, Inc.Aphakia, Cataract

Start: 2021-12-03End: 2024-12-16Updated: 2025-04-20